Pharmacists may continue making compounded versions of the weight-loss medication tirzepatide while the FDA revisits its decision to remove it.

The stock of Eli Lilly and Company LLY has declined 1.7% already this week, losing almost $14 billion of its market value.

Expanding access to new, highly effective weight-loss medications could prevent more than 40,000 deaths a year in the United ...

A trial, targeted at people living with obesity from Britain to Puerto Rico, is the first head-to-head comparison of the ...

The drugmaker's financial results are also impressive, spearheaded by tirzepatide, a therapy for diabetes and obesity that is ...

The 29-year-old influencer's binge-eating disorder was so bad in 2022 that she sought 'serious outpatient treatment at a ...

Both Wegovy and Mounjaro are given as weekly injections via pre-filled pens that can be self-administered into the upper arm, ...

STAT reporters discuss investors' interest in autoimmune disease, GLP-1 supply issues, and big moments from #STATSummit.

High blood pressure impairs one's breathing capacity by hardening the airways in the respiratory system, thereby increasing ...

The British government believes weight-loss drugs could play a role in its push to reduce the number of long-term unemployed ...

Hims & Hers is revolutionizing healthcare with affordable, convenient telehealth services, leading to a 260% stock increase in the last year. Read more here.

Millions of Americans rely on a new class of medications to manage chronic conditions like diabetes and obesity, with ...